Heal Precisely’s parent company, Precisely Medical Solutions, aims to improve patient advocacy and clinic advancement. We work with patients, doctors, and clinics to successfully navigate stressful changes occurring in the healthcare space while at the same time bringing promising new therapies like Heal Precisely to market.
“We consider ourselves to be a facilitator of change for doctors and patients alike,” said CEO Jennifer Rivard.
Heal Precisely is perfect example of Precisely Medical Solutions’ mission. Heal Precisely is the first clinic in Florida to offer amniotic allograft treatments for patients suffering from chronic wounds, such as bed sores, burns, and diabetic ulcers.
As the method of healthcare delivery continues to evolve, access to healthcare is improving for everyone. Likewise, the roles of the patient-doctor relationship continue to evolve and adapt to these changes. These include giving patients access to more information, increased cost transparency, and better use of technology to improve patient engagement.
Precisely Medical Solutions is proud to be the first company to bring the revolutionary Heal Precisely therapy for chronic wounds to the Sunshine State. As more scientific breakthroughs occur, Precisely Medical Solutions will evaluate their efficacy and work to bring the most promising therapies to market.
Next on the horizon for a Precisely Medical Solutions subsidiary roll-out is Breathe Precisely. Breathe Precisely is a piece of durable medical equipment (a vest that patients wear) that provides high-frequency chest wall oscillation for those with breathing problems. High-frequency chest wall oscillation (HFCWO) therapy effectively manages bronchiectasis and other chronic pulmonary conditions, such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis. HFCWO therapy works by producing an alternating flow of air into an inflatable garment that rapidly compresses and releases the chest wall at various selectable frequencies and pressures, resulting in an oscillation in airflow within the airways.
“We are continually seeking innovative, promising products and therapies that can drastically improve a patient’s overall quality of life,” said Rivard.
